Shopping Cart 0
Cart Subtotal
USD 0

Foundation for Innovative New Diagnostics - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Foundation for Innovative New Diagnostics

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Foundation for Innovative New Diagnostics Company Overview

Foundation for Innovative New Diagnostics Company Snapshot

Foundation for Innovative New Diagnostics Pipeline Products and Ongoing Clinical Trials Overview

Foundation for Innovative New Diagnostics-Pipeline Analysis Overview

Foundation for Innovative New Diagnostics-Key Facts

Foundation for Innovative New Diagnostics-Major Products and Services

Foundation for Innovative New Diagnostics Pipeline Products by Development Stage

Foundation for Innovative New Diagnostics Pipeline Products Overview

23l Conical Cup Blood Transfer Device

23l Conical Cup Blood Transfer Device Product Overview

5l Inverted Cup Blood Transfer Device

5l Inverted Cup Blood Transfer Device Product Overview

Antibody Detection Test

Antibody Detection Test Product Overview

Antigen Detection Test-Human African Trypanosomiasis

Antigen Detection Test-Human African Trypanosomiasis Product Overview

High Throughput LAMP Kit-Malaria

High Throughput LAMP Kit-Malaria Product Overview

LAM Antigen Detection Test

LAM Antigen Detection Test Product Overview

Lamp Assay-Buruli Ulcer

Lamp Assay-Buruli Ulcer Product Overview

MDR-XDRTB Color Test

MDR-XDRTB Color Test Product Overview

P. vivax Serology Test

P. vivax Serology Test Product Overview

Protein Antigen Capture Assay-Buruli Ulcer

Protein Antigen Capture Assay-Buruli Ulcer Product Overview

Rapid Diagnostic Test-Neoptrin/CXCL13

Rapid Diagnostic Test-Neoptrin/CXCL13 Product Overview

Single Format IgM Quantification Test

Single Format IgM Quantification Test Product Overview

Foundation for Innovative New Diagnostics-Key Competitors

Foundation for Innovative New Diagnostics-Key Employees

Foundation for Innovative New Diagnostics-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Foundation for Innovative New Diagnostics, Recent Developments

Jul 04, 2019: FIND signs USD 14.5 M Grant with Unitaid to evaluate Next-Generation Sequencing for Rapid, Affordable Diagnosis of Drug-Resistant Tuberculosis in Resource-Limited Settings

Feb 19, 2019: ImmunoPrecise Antibodies Collaborates with FIND to Help Advance New TB Diagnostic Test

Aug 28, 2018: Cochrane review looks at the accuracy of Xpert MTB/RIF for the diagnosis of extrapulmonary TB

Aug 06, 2018: CRM-FIND MoU on innovative Hepatitis C diagnostic test-BERNAMA

Aug 06, 2018: Simpler diagnostic Hepatitis C test at government facilities-BERNAMA

Jul 28, 2018: FIND announces new wave of activities to address the challenges threatening hepatitis C elimination through potential diagnostic technologies

Mar 27, 2012: BD And FIND Extend Pricing Agreement To Reach HIV-Positive Patients In India

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Foundation for Innovative New Diagnostics Pipeline Products by Equipment Type

Foundation for Innovative New Diagnostics Pipeline Products by Development Stage


List Of Table

List of Tables

Foundation for Innovative New Diagnostics Pipeline Products and Ongoing Clinical Trials Overview

Foundation for Innovative New Diagnostics Pipeline Products by Equipment Type

Foundation for Innovative New Diagnostics Pipeline Products by Indication

Foundation for Innovative New Diagnostics, Key Facts

Foundation for Innovative New Diagnostics, Major Products and Services

Foundation for Innovative New Diagnostics Number of Pipeline Products by Development Stage

Foundation for Innovative New Diagnostics Pipeline Products Summary by Development Stage

23l Conical Cup Blood Transfer Device-Product Status

23l Conical Cup Blood Transfer Device-Product Description

5l Inverted Cup Blood Transfer Device-Product Status

5l Inverted Cup Blood Transfer Device-Product Description

Antibody Detection Test-Product Status

Antibody Detection Test-Product Description

Antigen Detection Test-Human African Trypanosomiasis-Product Status

Antigen Detection Test-Human African Trypanosomiasis-Product Description

High Throughput LAMP Kit-Malaria-Product Status

High Throughput LAMP Kit-Malaria-Product Description

LAM Antigen Detection Test-Product Status

LAM Antigen Detection Test-Product Description

Lamp Assay-Buruli Ulcer-Product Status

Lamp Assay-Buruli Ulcer-Product Description

MDR-XDRTB Color Test-Product Status

MDR-XDRTB Color Test-Product Description

P. vivax Serology Test-Product Status

P. vivax Serology Test-Product Description

Protein Antigen Capture Assay-Buruli Ulcer-Product Status

Protein Antigen Capture Assay-Buruli Ulcer-Product Description

Rapid Diagnostic Test-Neoptrin/CXCL13-Product Status

Rapid Diagnostic Test-Neoptrin/CXCL13-Product Description

Single Format IgM Quantification Test-Product Status

Single Format IgM Quantification Test-Product Description

Foundation for Innovative New Diagnostics, Key Employees

Foundation for Innovative New Diagnostics, Other Locations

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Foundation for Innovative New Diagnostics, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Ziemer Ophthalmic Systems AG

Inpeco SA

Diagene laboratories inc

Axon Lab AG

Company Profile

Company Profile Title

Summary

Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Foundation for Innovative New Diagnostics

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Foundation for Innovative New Diagnostics Company Overview

Foundation for Innovative New Diagnostics Company Snapshot

Foundation for Innovative New Diagnostics Pipeline Products and Ongoing Clinical Trials Overview

Foundation for Innovative New Diagnostics-Pipeline Analysis Overview

Foundation for Innovative New Diagnostics-Key Facts

Foundation for Innovative New Diagnostics-Major Products and Services

Foundation for Innovative New Diagnostics Pipeline Products by Development Stage

Foundation for Innovative New Diagnostics Pipeline Products Overview

23l Conical Cup Blood Transfer Device

23l Conical Cup Blood Transfer Device Product Overview

5l Inverted Cup Blood Transfer Device

5l Inverted Cup Blood Transfer Device Product Overview

Antibody Detection Test

Antibody Detection Test Product Overview

Antigen Detection Test-Human African Trypanosomiasis

Antigen Detection Test-Human African Trypanosomiasis Product Overview

High Throughput LAMP Kit-Malaria

High Throughput LAMP Kit-Malaria Product Overview

LAM Antigen Detection Test

LAM Antigen Detection Test Product Overview

Lamp Assay-Buruli Ulcer

Lamp Assay-Buruli Ulcer Product Overview

MDR-XDRTB Color Test

MDR-XDRTB Color Test Product Overview

P. vivax Serology Test

P. vivax Serology Test Product Overview

Protein Antigen Capture Assay-Buruli Ulcer

Protein Antigen Capture Assay-Buruli Ulcer Product Overview

Rapid Diagnostic Test-Neoptrin/CXCL13

Rapid Diagnostic Test-Neoptrin/CXCL13 Product Overview

Single Format IgM Quantification Test

Single Format IgM Quantification Test Product Overview

Foundation for Innovative New Diagnostics-Key Competitors

Foundation for Innovative New Diagnostics-Key Employees

Foundation for Innovative New Diagnostics-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Foundation for Innovative New Diagnostics, Recent Developments

Jul 04, 2019: FIND signs USD 14.5 M Grant with Unitaid to evaluate Next-Generation Sequencing for Rapid, Affordable Diagnosis of Drug-Resistant Tuberculosis in Resource-Limited Settings

Feb 19, 2019: ImmunoPrecise Antibodies Collaborates with FIND to Help Advance New TB Diagnostic Test

Aug 28, 2018: Cochrane review looks at the accuracy of Xpert MTB/RIF for the diagnosis of extrapulmonary TB

Aug 06, 2018: CRM-FIND MoU on innovative Hepatitis C diagnostic test-BERNAMA

Aug 06, 2018: Simpler diagnostic Hepatitis C test at government facilities-BERNAMA

Jul 28, 2018: FIND announces new wave of activities to address the challenges threatening hepatitis C elimination through potential diagnostic technologies

Mar 27, 2012: BD And FIND Extend Pricing Agreement To Reach HIV-Positive Patients In India

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Foundation for Innovative New Diagnostics Pipeline Products by Equipment Type

Foundation for Innovative New Diagnostics Pipeline Products by Development Stage


List Of Table

List of Tables

Foundation for Innovative New Diagnostics Pipeline Products and Ongoing Clinical Trials Overview

Foundation for Innovative New Diagnostics Pipeline Products by Equipment Type

Foundation for Innovative New Diagnostics Pipeline Products by Indication

Foundation for Innovative New Diagnostics, Key Facts

Foundation for Innovative New Diagnostics, Major Products and Services

Foundation for Innovative New Diagnostics Number of Pipeline Products by Development Stage

Foundation for Innovative New Diagnostics Pipeline Products Summary by Development Stage

23l Conical Cup Blood Transfer Device-Product Status

23l Conical Cup Blood Transfer Device-Product Description

5l Inverted Cup Blood Transfer Device-Product Status

5l Inverted Cup Blood Transfer Device-Product Description

Antibody Detection Test-Product Status

Antibody Detection Test-Product Description

Antigen Detection Test-Human African Trypanosomiasis-Product Status

Antigen Detection Test-Human African Trypanosomiasis-Product Description

High Throughput LAMP Kit-Malaria-Product Status

High Throughput LAMP Kit-Malaria-Product Description

LAM Antigen Detection Test-Product Status

LAM Antigen Detection Test-Product Description

Lamp Assay-Buruli Ulcer-Product Status

Lamp Assay-Buruli Ulcer-Product Description

MDR-XDRTB Color Test-Product Status

MDR-XDRTB Color Test-Product Description

P. vivax Serology Test-Product Status

P. vivax Serology Test-Product Description

Protein Antigen Capture Assay-Buruli Ulcer-Product Status

Protein Antigen Capture Assay-Buruli Ulcer-Product Description

Rapid Diagnostic Test-Neoptrin/CXCL13-Product Status

Rapid Diagnostic Test-Neoptrin/CXCL13-Product Description

Single Format IgM Quantification Test-Product Status

Single Format IgM Quantification Test-Product Description

Foundation for Innovative New Diagnostics, Key Employees

Foundation for Innovative New Diagnostics, Other Locations

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Foundation for Innovative New Diagnostics, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Ziemer Ophthalmic Systems AG

Inpeco SA

Diagene laboratories inc

Axon Lab AG